Israel’s Precise Bio (see here previously) has reported the first successful human implantation of its 3D-printed cornea implant, constructed of functional human eye cells cultured in a laboratory. Israel’s Corneat has previously implanted synthetic corneas (see here previously). https://www.fiercebiotech.com/medtech/precise-bio-completes-first-human-cornea-transplant-using-3d-printed-lab-grown-tissue

Israel’s Precise Bio is developing 3D-printed synthetic corneas and retinas to enable visually impaired people to see clearly again. Precise Bio takes donated cells, grows them in the lab, and then 3D-prints them onto a biological scaffold. Looking forward to … Continue reading →

Hebrew University of Jerusalem scientists have developed a technique that distinguishes the precise subgroup of a bacteria strain that is causing infection. It explains why antibiotics and vaccines sometimes fail. The discovery can lead to more precise treatments. https://www.timesofisrael.com/using-novel-method-to-compare-subgroups-israeli-researchers-unlock-bacterias-secrets/ https://www.cell.com/cell/fulltext/S0092-8674(25)00915-8

Israel’s Biolojic Design is developing an AI platform to generate antibodies that have specific targets and biological effects. It instructs the immune system to precisely attack the causes of disease, such as the mechanism underlying autoimmune disease, cancer or diabetes. … Continue reading →

Israel is establishing a consortium to make CRISPR genome editing more precise. Israel’s Innovation Authority has allocated NIS 36 million to CRISPR-IL, for the country’s academic institutions and bio-techs to use AI to advance the technology for repairing disease-causing mutations. … Continue reading →

Israeli startup BioShai is developing the world’s first simple blood test for the early diagnosis of Parkinson’s Disease (PD). The PDx test measures changes in molecules associated with PD and can lead to more precise treatments and a higher quality … Continue reading →

ActiView’s Israeli-developed ActiSight CT-navigation system guides a surgical needle to the precise location for pulmonary biopsies and tumour procedures. ActiView is apparently in advanced talks about a joint development, marketing and distribution deal with a major US medical devices company. … Continue reading →